Silverfin false false 31/03/2024 31/03/2024 01/04/2023 The principal activity of the Company during the financial year was of providing medical services. P Barrett 12/01/2010 S A Barrett 12/01/2010 07123131 2024-03-31 07123131 bus:Director1 2024-03-31 07123131 bus:Director2 2024-03-31 07123131 2023-03-31 07123131 core:CurrentFinancialInstruments 2024-03-31 07123131 core:CurrentFinancialInstruments 2023-03-31 07123131 core:Non-currentFinancialInstruments 2024-03-31 07123131 core:Non-currentFinancialInstruments 2023-03-31 07123131 2023-04-01 2024-03-31 07123131 bus:Micro-entities 2023-04-01 2024-03-31 07123131 bus:FilletedAccounts 2023-04-01 2024-03-31 07123131 bus:AuditExemptWithAccountantsReport 2023-04-01 2024-03-31 07123131 bus:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 07123131 bus:Director1 2023-04-01 2024-03-31 07123131 bus:Director2 2023-04-01 2024-03-31 07123131 2022-04-01 2023-03-31 iso4217:GBP xbrli:pure

Company No: 07123131 (England and Wales)

LONDON RHEUMATOLOGY CENTRE LTD

Unaudited Financial Statements
For the financial year ended 31 March 2024
Pages for filing with the registrar

LONDON RHEUMATOLOGY CENTRE LTD

UNAUDITED FINANCIAL STATEMENTS

For the financial year ended 31 March 2024

Contents

LONDON RHEUMATOLOGY CENTRE LTD

STATEMENT OF FINANCIAL POSITION

As at 31 March 2024
LONDON RHEUMATOLOGY CENTRE LTD

STATEMENT OF FINANCIAL POSITION (continued)

For the financial year ended 31 March 2024
2024 2023
£ £
Fixed assets 23,640 26,412
Current assets 192,543 207,782
Creditors: amounts falling due within one year ( 41,587) ( 45,875)
Net current assets 150,956 161,907
Total assets less current liabilities 174,596 188,319
Creditors: amounts falling due after more than one year ( 12,915) ( 23,138)
Accruals and deferred income ( 16,616) ( 10,000)
Net assets 145,065 155,181
Capital and reserves 145,065 155,181

For the financial year ending 31 March 2024 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The financial statements of London Rheumatology Centre Ltd (registered number: 07123131) were approved and authorised for issue by the Board of Directors and were signed on its behalf by:

S A Barrett
Director

24 December 2024

LONDON RHEUMATOLOGY CENTRE LTD

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 March 2024
LONDON RHEUMATOLOGY CENTRE LTD

NOTES TO THE FINANCIAL STATEMENTS (continued)

For the For the financial year ended 31 March 2024

1. Company information

The Company is a private company limited by shares and is incorporated in the United Kingdom and registered in England and Wales (Company no. 07123131). The address of its registered office is 35 Ballards Lane, London, N3 1XW, United Kingdom.

2. Employees

2024 2023
Number Number
Monthly average number of persons employed by the Company during the financial year, including directors 4 4

3. Directors’ benefits: advances, credit and guarantees

Advances

An advance was made to the directors of £64,585 (2023: £69,508) and Interest of £1,148 (2023: £821) was charged on the loan. The loan was repaid within 9 months of the year-end date.